Cell Therapy QC Automation: Getting Integration Right

As cell therapy manufacturing scales, quality control must keep pace. High testing costs, long turnaround times, and outdated analytical technologies can prevent manufacturers from acting on results when they matter most. Solving these challenges requires more than automating existing processes. It calls for a new QC model built around rapid decision-making, integrated data, connected workflows, and advanced analytical methods. Perspectives from pharma, engineering, technology, and AI reveal where current bottlenecks occur and what is needed to move beyond them.

Explore how bringing testing closer to manufacturing and improving the flow of data can help QC evolve from a release-stage constraint into a more responsive part of the manufacturing process.